Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers

Pawan Kumar1, Vinod Kumar2, Ravinder Kumar3

  • 1Department of Materials Science and Nanotechnology, Deenbandhu Chhotu Ram University of Science and Technology, Murthal 131039, India.

Insights

Pectin nanocarriers successfully delivered ceftizoxime, a third-generation cephalosporin antibiotic, showing sustained release and potent antimicrobial activity against various bacteria. This novel nanoformulation offers a promising approach for treating bacterial infections.

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science
  • Nanotechnology

Background:

  • Ceftizoxime is a third-generation cephalosporin antibiotic effective against bacterial infections.
  • Pectin, a biopolymer, offers biocompatibility and tunable properties for drug delivery applications.
  • Developing effective nanocarriers is crucial for enhancing antibiotic efficacy and stability.

Purpose of the Study:

  • To synthesize and optimize ceftizoxime-loaded pectin nanocarriers (CPN).
  • To characterize the physicochemical properties and in vitro drug release of CPN.
  • To evaluate the antimicrobial activity of CPN against specific bacterial strains.

Main Methods:

  • Ceftizoxime-loaded pectin nanocarriers (CPN) were synthesized using the solvent displacement method.
  • Response surface methodology with Design-Expert software was employed for nanoformulation optimization.
  • In vitro characterization included particle size, morphology (TEM), FTIR, and drug release studies via dialysis.
  • Antimicrobial activity was assessed against Bacillus cereus, Bacillus polymyxa, Enterobacter aerogenes, and Pseudomonas aeruginosa.

Main Results:

  • TEM revealed irregular shaped nanoparticles ranging from 29-110 nm.
  • In vitro studies demonstrated sustained drug release of ceftizoxime from pectin nanocarriers over 24 hours.
  • CPN exhibited significant antimicrobial activity against all tested bacterial pathogens.

Conclusions:

  • Pectin serves as a suitable nanocarrier for ceftizoxime, enhancing its delivery.
  • The developed CPN formulation exhibits sustained drug release and effective antimicrobial properties.
  • This pectin-based nanoformulation holds potential for improved treatment of bacterial infections.